In this paper, we present results from three different simulation models that are used to determine the dose distribution around a W-188/Re-188 coronary brachytherapy source with EGS4 Monte Carlo simulations. The thre...
详细信息
In this paper, we present results from three different simulation models that are used to determine the dose distribution around a W-188/Re-188 coronary brachytherapy source with EGS4 Monte Carlo simulations. The three models are found to give similar results within 10%. Agreement was found with experimental data from measurements in a PMMA phantom. It has been shown that in the therapeutically relevant region the beta line source can be characterized by the radial depth-dose distribution in water.
OBJECTIVES The purpose of this study was to evaluate the effect of IR on thrombus formation and dissection repair following overstretch balloon injury in porcine coronary arteries. BACKGROUND Exposure of blood to the ...
详细信息
OBJECTIVES The purpose of this study was to evaluate the effect of IR on thrombus formation and dissection repair following overstretch balloon injury in porcine coronary arteries. BACKGROUND Exposure of blood to the injured arterial wall after percutaneous transluminal coronary angioplasty (PTCA) induces thrombus formation and inflammation in the dissection plane. Neointima formation is related to smooth muscle cell (SMC) proliferation and migration into the preformed thrombus. Intracoronary radiation (IR) with doses of 10 to 25 Gy using either beta or gamma emitters can prevent neointima accumulation by reducing SMC proliferation. However, there are some indications that IR may delay the process of dissection repair after PTCA. The purpose of this study was to evaluate the effect of IR on thrombus formation and dissection repair after overstretch balloon injury in porcine coronary arteries. METHODS Forty porcine coronaries were injured by balloon overstretch followed by either 0 or 18 Gy of Y-90 prescribed to 1.2 mm from the balloon center. The animals were euthanized 14 days after treatment, and intimal area (IA) and IA corrected for medial fracture length (IA/FL) were quantified by digital image analysis. Dissections were quantified by tracing the length, thickness and area behind the dissection flap. The rate of dissections was calculated for each group. Thrombi were identified and designated as intraluminal thrombus or thrombus within dissection planes (mural thrombus), and area measurements were obtained. RESULTS The irradiated group showed a significant reduction of IA/FL (0.55 +/- 0.29 vs. 0.05 +/- 0.09;p < 0.001). No difference was observed in the rare of dissection between control and irradiated arteries (77% vs. 88%, respectively). The control group showed a smaller dissection area (0.19 +/- 0.28 mm(2) vs. 0.32 +/- 0.29 mm;p < 0.05) with smaller mural thrombi (0.03 +/- 0.01 mm(2) vs. 0.29 +/- 0.30 mm2;p < 0.001). A strong correlation between dissection a
Iridium-192 (gamma)-radiation is effective in preventing recurrent in-stent restenosis by reducing neointimal hyperplasia;ls illustrated by intravascular ultrasound study and plaque area-length plot. This analytic tec...
详细信息
Iridium-192 (gamma)-radiation is effective in preventing recurrent in-stent restenosis by reducing neointimal hyperplasia;ls illustrated by intravascular ultrasound study and plaque area-length plot. This analytic technique will further our understanding of vessel behavior to radiant energy source both inside and outside the stented coronary artery segments.
OBJECTIVES The aim of this study was to determine the natural history of postangioplasty intravascular ultrasound (IVUS)-detectcd dissections and to assess the influence of intracoronary beta-radiation on dissection r...
详细信息
OBJECTIVES The aim of this study was to determine the natural history of postangioplasty intravascular ultrasound (IVUS)-detectcd dissections and to assess the influence of intracoronary beta-radiation on dissection resolution. BACKGROUND Intracoronary radiotherapy is considered to impair exaggerated vessel healing. Conversely, excessive healing impairment may increase the risk of complications due to unhealed dissection. Alternatively, residual dissection may represent an innocent marker of adequate therapy. METHODS Immediate postangioplastic and six-month follow-up IVUS studies of 94 patients in the IVUS substudy of the: MultiVitamins and Probucol (MVP) trial and 26 nonstented patients in the Beta Energy Restenosis Trial (BERT) were analyzed for the presence or absence of dissection. RESULTS Of the 28 patients with postangioplasty dissections in MVP, only one had evidence of residual dissection at six months (95% confidence interval [CT] for failure rate 0.2%;20.2%). Conversely, 9 of 16 dissections had healed in BERT (95% CI for failure rate 30.6%;79.2%) (p < 0.0002). Nevertheless, an index based on dissection are and length demonstrated improvement in the irradiated patients. Irradiated patients with residual dissections showed significant increase in lumen area at six-months (5.10 +/- 0.98 to 7.11 +/- 2.61 mm(2), p < 0.02) not noted when there was resolution of the: dissection (6.03 +/- 2.38 to 6.36 +/- 3.33 mm(2), p = NS). In both groups the external elastic membrane area was unchanged at follow-up. CONCLUSION Resolution appears to be the natural history of IVUS-detected dissections in most cases. Significant resolution of dissection occurs following intracoronary beta-radiation as reflected in reduced dissection index at six-months in these patients, although significant impairment of vessel wall healing was noted. (J Am Coil Cardiol 2000;36:59-64) (C) 2000 by the American College of Cardiology.
OBJECTIVES The study sought to determine the incidence and predictors of late total occlusion (LTO, >30 days) in-patients with ill-stent restenosis who were treated with intracoronary radiation. BACKGROUND Intracor...
详细信息
OBJECTIVES The study sought to determine the incidence and predictors of late total occlusion (LTO, >30 days) in-patients with ill-stent restenosis who were treated with intracoronary radiation. BACKGROUND Intracoronary radiation both with beta and gamma emitters has been shown to reduce recurrent in-stent restenosis. METHODS We reviewed the records of 473 patients who presented with in-stent restenosis and who were enrolled in various radiation protocols, whether randomized to placebo versus radiation or entered into registries. There were 165 placebo and 308 radiated patients, including both gamma and beta emitters. Maximum dose to the Vessel wall was 30 to 55 Gy. Following radiation, all patients received antiplatelet therapy with aspirin and either ticlopidine or clopidogrel for one month. All patients completed at least six months of angiographic follow-up. RESULTS The LTO was documented in 28 patients (9.1%) from the irradiated group versus 2 placebo patients (1.20%), p < 0.0001. The LTO rates were similar across studies and emitters. In the irradiated group, LTO presented as acute myocardial infarction in 12 patients (43%), unstable angina in 14 (50%), and asymptotic in 2 (7%). Mean time to LTO was 5.4 +/- 3.2 months in the irradiated group versus 4.5 +/- 2.1 in placebo patients (p = NS). The overall rate of restenting for the entire study group at the time of radiation was 48.6%. Importantly, new stents were placed in 82% of the irradiated and in 100% of the placebo patients who presented with LTO. Multivariate analysis determined that new stenting was the main predictor of LTO. CONCLUSION Intracoronary radiation for patients with in-stent restenosis is associated with a high rate of LTO. Restenting may contribute late thrombosis. Prolonged antiplatelet therapy (up to six months) should be considered for these patients. (J Am Cell Cardiol 2000;36:65-8) (C) 2000 by the American College of Cardiology.
暂无评论